Marketdash
Back to News

Market Roundup: Carnival Makes Waves, Caterpillar Crushes It, And Meta Gets Left Behind

MarketDash Editorial Team
5 hours ago
Markets ended the week in the green as cooling inflation data sparked hopes for rate cuts ahead, while stock-specific stories stole the spotlight. From cannabis rallies to cruise line comebacks, here's what moved the needle for investors this week.

Markets closed out the week with moderate gains, and honestly, it was one of those weeks where the macro backdrop played nice for a change. Softer inflation data combined with stable unemployment numbers gave investors reason to believe the Fed might actually cut rates in 2026. The Dow Jones Industrial Average and S&P 500 both climbed higher, getting a lift from broad-based sector strength, while the Nasdaq Composite bounced back from earlier weakness thanks to a tech recovery. The vibe? Inflation is cooling without torching the job market, which is exactly what you want if you're hoping for that elusive soft landing.

Earnings reports drove a lot of the action this week. Micron Technology Inc. (MU) crushed expectations and raised its guidance, which set off a rally across AI-related semiconductor stocks. Meanwhile, Nike Inc. (NKE) went the other direction after issuing cautious commentary on global demand, especially in China, raising fresh concerns about consumer strength. Still, cyclical stocks and dividend-paying names picked up steam as portfolio managers started positioning for a potentially lower-rate environment in 2026.

Transportation and travel names showed real resilience. FedEx Corp. (FDX) posted solid quarterly results that boosted confidence in global shipping demand, while Carnival Corp. (CCL) offered upbeat forward guidance, signaling that consumers still have a serious appetite for cruises. The overall takeaway from the week? Sure, macro uncertainty isn't going anywhere, but there are pockets of genuine strength across sectors that are allowing equity markets to grind higher as we head into year-end.

Let's dive into some of the most interesting bullish and bearish stories from the past week.

The Bullish Case

Cannabis Stocks Light Up on Rescheduling Hopes

Cannabis stocks went on a tear this week as investors reacted to reports that President Donald Trump could reschedule marijuana from Schedule I to Schedule III. That might sound like bureaucratic jargon, but it's actually a huge deal for the sector. The rescheduling would ease the tax burden on cannabis companies and significantly boost profitability expectations. Tilray Brands Inc. (TLRY), Canopy Growth Corp. (CGC), and the AdvisorShares Pure US Cannabis ETF (MSOS) all rallied on the news. It's the kind of policy shift that could transform the economics of the entire industry overnight.

Carnival's Comeback Is No Joke

Carnival Corporation & plc (CCL) delivered a serious beat in Q4, posting record net income and adjusted EPS of 34¢. But here's what really caught investors' attention: the company reinstated its quarterly dividend and forecast stronger 2026 adjusted net income of about $3.5 billion. That's a strong signal that the cruise line's recovery isn't just real, it's accelerating. Record bookings, robust demand, and expanding margins all contributed to the strong performance, and shares responded accordingly. After the beating cruise lines took during the pandemic, this feels like vindication.

Caterpillar Quietly Crushes the Competition

While everyone was busy talking about Nvidia Corp. (NVDA), Caterpillar Inc. (CAT) quietly became the top-performing Dow stock in 2025. The heavy equipment maker is up over 62% this year, adding roughly $1.7 billion in value to stakes held by the Bill & Melinda Gates Foundation and Fisher Asset Management. It's one of those reminders that the flashiest stocks don't always deliver the best returns. Sometimes boring construction equipment wins the race.

Other Bullish Highlights

Alibaba is reportedly poised to win big in China's AI boom according to analyst coverage. Frontier stock climbed on merger talks with Spirit Aviation. And Radiopharm Theranostics stock rallied over 140% this week, catching the attention of momentum traders everywhere.

The Bearish Case

JPMorgan Says AI Hype Has Peaked

JPMorgan Chase & Co. (JPM) issued a reality check this week, warning that the generative-AI narrative that dominated markets in 2025 hasn't yet translated into proportional profits. Their analysts expect 2026 to be the year where earnings actually matter more than hype, with investors likely pivoting toward companies that can show clear ROI rather than just promise. It's a sobering reminder that eventually, the market cares about cash flow, not just cool technology.

Meta Becomes the Magnificent 7 Laggard

Meta Platforms Inc. (META) has become the biggest laggard among the Magnificent 7 stocks, trading roughly 19% below its 52-week high while its peers sit much closer to their peaks. That's a notable underperformance for a company that's supposed to be at the forefront of AI and digital advertising. Interestingly, Jim Cramer pointed out that markets typically bottom in mid-December, which has some traders eyeing Meta as a potential year-end rebound candidate. Whether that happens or not, the stock's relative weakness is hard to ignore.

Novo Nordisk Loses Ground to Eli Lilly

The weight-loss drug wars are heating up, and Novo Nordisk A/S (NVO) is on the losing end right now. The stock has slid sharply this year after the company lowered its 2025 sales guidance and faced tougher competition in the obesity treatment space. Meanwhile, Eli Lilly and Co. (LLY) has been gaining market share and seeing its stock rise as its broader pipeline and rival obesity treatments outpace Novo's growth. It's a classic case of a market leader getting overtaken by a more aggressive competitor.

Other Bearish Developments

Nike stock slipped despite beating Q2 earnings expectations, with investors waiting for more clarity on the outlook during the conference call. Oracle stock saw an intensifying sell-off that has traders scratching their heads about what's driving the move. And Pfizer is facing questions about slower 2026 growth despite its pipeline push and cost-cutting efforts.

The bottom line? This week had something for everyone. Bulls found plenty to celebrate in sectors ranging from travel to semiconductors, while bears got ammunition from concerns about AI monetization and competitive pressure in high-profile industries. As we head deeper into December, the tug-of-war between optimism about rate cuts and skepticism about earnings growth is likely to continue shaping market sentiment.

Back to News

Market Roundup: Carnival Makes Waves, Caterpillar Crushes It, And Meta Gets Left Behind

MarketDash Editorial Team
5 hours ago
Markets ended the week in the green as cooling inflation data sparked hopes for rate cuts ahead, while stock-specific stories stole the spotlight. From cannabis rallies to cruise line comebacks, here's what moved the needle for investors this week.

Markets closed out the week with moderate gains, and honestly, it was one of those weeks where the macro backdrop played nice for a change. Softer inflation data combined with stable unemployment numbers gave investors reason to believe the Fed might actually cut rates in 2026. The Dow Jones Industrial Average and S&P 500 both climbed higher, getting a lift from broad-based sector strength, while the Nasdaq Composite bounced back from earlier weakness thanks to a tech recovery. The vibe? Inflation is cooling without torching the job market, which is exactly what you want if you're hoping for that elusive soft landing.

Earnings reports drove a lot of the action this week. Micron Technology Inc. (MU) crushed expectations and raised its guidance, which set off a rally across AI-related semiconductor stocks. Meanwhile, Nike Inc. (NKE) went the other direction after issuing cautious commentary on global demand, especially in China, raising fresh concerns about consumer strength. Still, cyclical stocks and dividend-paying names picked up steam as portfolio managers started positioning for a potentially lower-rate environment in 2026.

Transportation and travel names showed real resilience. FedEx Corp. (FDX) posted solid quarterly results that boosted confidence in global shipping demand, while Carnival Corp. (CCL) offered upbeat forward guidance, signaling that consumers still have a serious appetite for cruises. The overall takeaway from the week? Sure, macro uncertainty isn't going anywhere, but there are pockets of genuine strength across sectors that are allowing equity markets to grind higher as we head into year-end.

Let's dive into some of the most interesting bullish and bearish stories from the past week.

The Bullish Case

Cannabis Stocks Light Up on Rescheduling Hopes

Cannabis stocks went on a tear this week as investors reacted to reports that President Donald Trump could reschedule marijuana from Schedule I to Schedule III. That might sound like bureaucratic jargon, but it's actually a huge deal for the sector. The rescheduling would ease the tax burden on cannabis companies and significantly boost profitability expectations. Tilray Brands Inc. (TLRY), Canopy Growth Corp. (CGC), and the AdvisorShares Pure US Cannabis ETF (MSOS) all rallied on the news. It's the kind of policy shift that could transform the economics of the entire industry overnight.

Carnival's Comeback Is No Joke

Carnival Corporation & plc (CCL) delivered a serious beat in Q4, posting record net income and adjusted EPS of 34¢. But here's what really caught investors' attention: the company reinstated its quarterly dividend and forecast stronger 2026 adjusted net income of about $3.5 billion. That's a strong signal that the cruise line's recovery isn't just real, it's accelerating. Record bookings, robust demand, and expanding margins all contributed to the strong performance, and shares responded accordingly. After the beating cruise lines took during the pandemic, this feels like vindication.

Caterpillar Quietly Crushes the Competition

While everyone was busy talking about Nvidia Corp. (NVDA), Caterpillar Inc. (CAT) quietly became the top-performing Dow stock in 2025. The heavy equipment maker is up over 62% this year, adding roughly $1.7 billion in value to stakes held by the Bill & Melinda Gates Foundation and Fisher Asset Management. It's one of those reminders that the flashiest stocks don't always deliver the best returns. Sometimes boring construction equipment wins the race.

Other Bullish Highlights

Alibaba is reportedly poised to win big in China's AI boom according to analyst coverage. Frontier stock climbed on merger talks with Spirit Aviation. And Radiopharm Theranostics stock rallied over 140% this week, catching the attention of momentum traders everywhere.

The Bearish Case

JPMorgan Says AI Hype Has Peaked

JPMorgan Chase & Co. (JPM) issued a reality check this week, warning that the generative-AI narrative that dominated markets in 2025 hasn't yet translated into proportional profits. Their analysts expect 2026 to be the year where earnings actually matter more than hype, with investors likely pivoting toward companies that can show clear ROI rather than just promise. It's a sobering reminder that eventually, the market cares about cash flow, not just cool technology.

Meta Becomes the Magnificent 7 Laggard

Meta Platforms Inc. (META) has become the biggest laggard among the Magnificent 7 stocks, trading roughly 19% below its 52-week high while its peers sit much closer to their peaks. That's a notable underperformance for a company that's supposed to be at the forefront of AI and digital advertising. Interestingly, Jim Cramer pointed out that markets typically bottom in mid-December, which has some traders eyeing Meta as a potential year-end rebound candidate. Whether that happens or not, the stock's relative weakness is hard to ignore.

Novo Nordisk Loses Ground to Eli Lilly

The weight-loss drug wars are heating up, and Novo Nordisk A/S (NVO) is on the losing end right now. The stock has slid sharply this year after the company lowered its 2025 sales guidance and faced tougher competition in the obesity treatment space. Meanwhile, Eli Lilly and Co. (LLY) has been gaining market share and seeing its stock rise as its broader pipeline and rival obesity treatments outpace Novo's growth. It's a classic case of a market leader getting overtaken by a more aggressive competitor.

Other Bearish Developments

Nike stock slipped despite beating Q2 earnings expectations, with investors waiting for more clarity on the outlook during the conference call. Oracle stock saw an intensifying sell-off that has traders scratching their heads about what's driving the move. And Pfizer is facing questions about slower 2026 growth despite its pipeline push and cost-cutting efforts.

The bottom line? This week had something for everyone. Bulls found plenty to celebrate in sectors ranging from travel to semiconductors, while bears got ammunition from concerns about AI monetization and competitive pressure in high-profile industries. As we head deeper into December, the tug-of-war between optimism about rate cuts and skepticism about earnings growth is likely to continue shaping market sentiment.